Increase in tartrate-resistant acid phosphatase of bone at the early stage of ascorbic acid deficiency in the ascorbate-requiring Osteogenic Disorder Shionogi (ODS) rat.
The effect of ascorbic acid deficiency on bone metabolism was evaluated using the ascorbate-requiring Osteogenic Disorder Shionogi (ODS) rat model. Ascorbic acid (Asc)-deficient rats gained body weight in a manner similar to Asc-supplemented rats (control) during 3 weeks, but began to lose weight during the 4th week of Asc deficiency. The tartrate-resistant acid phosphatase (TRAP) activity in serum increased to about 2-fold the control value in the rats fed the Asc-free diet for 2, 3, and 4 weeks (AscD2, AscD3, and AscD4), while a decrease in the alkaline phosphatase (ALP) activity was observed only in AscD4 rats. The serum pyridinoline cross-linked carboxyterminal telopeptide of type I collagen (ICTP) level significantly increased to 1.3-, 1.4-, and 1.9-fold of that in the controls in AscD2, D3, and D4, respectively. The ALP activity in the distal femur was unchanged in AscD1, D2, and D3, but decreased to 50% of the control level in AscD4 rats. The TRAP activity in the distal femur increased to about 2-fold of that in the controls in the AscD2 and D3 and decreased to the control level in the AscD4 rats. The amount of hydroxyproline in the distal femur significantly decreased to about 80%, 70%, and 60% of the control in AscD2, D3, and D4 rats, respectively. These decreases were associated with a similar reduction in the calcium content of the distal femur. Histochemical analysis of the distal femur showed an increase in TRAP-positive cells in AscD2 and AscD3 rats and a decrease in the trabecular bone in AscD2, D3, and D4 rats. These results suggested that a deficiency of Asc stimulated bone resorption at an early stage, followed by a decrease in bone formation in mature ODS rats which already had a well-developed collagen matrix and fully differentiated osteoblasts.
Goto
A
A
Department of Food Science and Nutrition, Nara Women's University, Nara 630, Japan.
Tsukamoto
I
I
D000135:Acid Phosphatase / Q000097:blood / Q000378:metabolism*; D000469:Alkaline Phosphatase / Q000097:blood / Q000378:metabolism; D000818:Animals; D001206:Ascorbic Acid Deficiency / Q000503:physiopathology*; D001835:Body Weight; D001862:Bone Resorption; D002118:Calcium / Q000032:analysis; D024042:Collagen Type I; D004195:Disease Models, Animal; D005260:Female; D005269:Femur / Q000737:chemistry / Q000201:enzymology*; D006909:Hydroxyproline / Q000032:analysis; D007150:Immunohistochemistry; D007527:Isoenzymes / Q000097:blood / Q000378:metabolism*; D009842:Oligopeptides; D010446:Peptide Fragments / Q000097:blood / Q000378:metabolism; D010455:Peptides; D011347:Procollagen / Q000097:blood / Q000378:metabolism; D051381:Rats; D000071681:Tartrate-Resistant Acid Phosphatase; D013997:Time Factors
D024042:Collagen Type I; D007527:Isoenzymes; D009842:Oligopeptides; D010446:Peptide Fragments; D010455:Peptides; D011347:Procollagen; C052929:collagen type I trimeric cross-linked peptide; C425644:isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone; D000469:Alkaline Phosphatase; D000135:Acid Phosphatase; D000071681:Tartrate-Resistant Acid Phosphatase; D006909:Hydroxyproline; D002118:Calcium